268 related articles for article (PubMed ID: 31069151)
1.
Gur C; Maalouf N; Shhadeh A; Berhani O; Singer BB; Bachrach G; Mandelboim O
Oncoimmunology; 2019; 8(6):e1581531. PubMed ID: 31069151
[No Abstract] [Full Text] [Related]
2. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Gur C; Ibrahim Y; Isaacson B; Yamin R; Abed J; Gamliel M; Enk J; Bar-On Y; Stanietsky-Kaynan N; Coppenhagen-Glazer S; Shussman N; Almogy G; Cuapio A; Hofer E; Mevorach D; Tabib A; Ortenberg R; Markel G; Miklić K; Jonjic S; Brennan CA; Garrett WS; Bachrach G; Mandelboim O
Immunity; 2015 Feb; 42(2):344-355. PubMed ID: 25680274
[TBL] [Abstract][Full Text] [Related]
3. CEACAM1 Activation by CbpF-Expressing
Shhadeh A; Galaski J; Alon-Maimon T; Fahoum J; Wiener R; Slade DJ; Mandelboim O; Bachrach G
Front Cell Infect Microbiol; 2021; 11():699015. PubMed ID: 34395310
[TBL] [Abstract][Full Text] [Related]
4. Targeting Programmed
Ganesan K; Guo S; Fayyaz S; Zhang G; Xu B
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635333
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a Fap2 peptide mimotope of
Guevarra LA; Afable ACF; Belza PJO; Dy KJS; Lee SJQ; Sy-Ortin TT; Albano PMSP
Infect Agent Cancer; 2018; 13():11. PubMed ID: 29619076
[TBL] [Abstract][Full Text] [Related]
6. Colon Cancer-Associated
Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
[No Abstract] [Full Text] [Related]
7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
8.
Galaski J; Shhadeh A; Umaña A; Yoo CC; Arpinati L; Isaacson B; Berhani O; Singer BB; Slade DJ; Bachrach G; Mandelboim O
Front Cell Infect Microbiol; 2021; 11():692544. PubMed ID: 34336716
[No Abstract] [Full Text] [Related]
9. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.
Abed J; Emgård JE; Zamir G; Faroja M; Almogy G; Grenov A; Sol A; Naor R; Pikarsky E; Atlan KA; Mellul A; Chaushu S; Manson AL; Earl AM; Ou N; Brennan CA; Garrett WS; Bachrach G
Cell Host Microbe; 2016 Aug; 20(2):215-25. PubMed ID: 27512904
[TBL] [Abstract][Full Text] [Related]
10. The
Gur C; Maalouf N; Gerhard M; Singer BB; Emgård J; Temper V; Neuman T; Mandelboim O; Bachrach G
Oncoimmunology; 2019; 8(4):e1553487. PubMed ID: 30906650
[TBL] [Abstract][Full Text] [Related]
11. The Role of
Pignatelli P; Nuccio F; Piattelli A; Curia MC
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.
Parhi L; Alon-Maimon T; Sol A; Nejman D; Shhadeh A; Fainsod-Levi T; Yajuk O; Isaacson B; Abed J; Maalouf N; Nissan A; Sandbank J; Yehuda-Shnaidman E; Ponath F; Vogel J; Mandelboim O; Granot Z; Straussman R; Bachrach G
Nat Commun; 2020 Jun; 11(1):3259. PubMed ID: 32591509
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.
Wu J; Li Q; Fu X
Transl Oncol; 2019 Jun; 12(6):846-851. PubMed ID: 30986689
[TBL] [Abstract][Full Text] [Related]
15.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
16. The role of
Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
[TBL] [Abstract][Full Text] [Related]
17. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
[TBL] [Abstract][Full Text] [Related]
19. Impact of
Kim YJ; Kim BK; Park SJ; Kim JH
World J Gastroenterol; 2021 Aug; 27(29):4879-4889. PubMed ID: 34447232
[TBL] [Abstract][Full Text] [Related]
20. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.
Coppenhagen-Glazer S; Sol A; Abed J; Naor R; Zhang X; Han YW; Bachrach G
Infect Immun; 2015 Mar; 83(3):1104-13. PubMed ID: 25561710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
